Evaluation of Biomarkers in Active Alzheimer's Disease Intervention Clinical Trials – The Biomarker Observatory

Abstract

Background: Biomarkers are critically important for Alzheimer's Disease (AD) drug development. They have a role in patient diagnosis and trial eligibility, pharmacodynamic changes, safety, monitoring, disease modification, and target engagement.

The paper